Optimizing Outcomes in Patients With Irritable Bowel Syndrome in Pharmacy Practice

CAN-eng

$0

free

CCCEP,OPQ

30 min

Gastroenterology

1.0 Credits

Take this Course
LEARN MORE

Course Description

Irritable bowel syndrome (IBS) is a common gastrointestinal (GI) disorder characterized by recurrent abdominal pain, altered bowel habits (such as constipation, diarrhea, or both), and bloating. The goal of IBS management is to improve symptoms related to IBS, prevent complications associated with less useful testing and treatment, and improve the patient’s quality of life.

This program will provide participants with key information about recommended therapies for patients with IBS.

Course Details

Expiry Date: 2025-10-02
Professions: Pharmacy

Faculty

  • Flavio Habal, PhD, MD, FRCPC
  • Jessica Chan, MD, MPH, PhD, FRCPC
  • Christine Palmay, MD, CCFP, FCFP
  • Sofia Nastis, BMSc, MD, CCFP
  • Carlene Oleksyn, RPh, APA, CDE, BSP, CTH
  • Betty Golightly, RPh

Accreditation

This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1.0 CEU(s). CCCEP File Number: 1066-2024-3852-I-P

This continuing educational activity has been accredited by the OPQ; 0.5 continuing education units/credits will be awarded to pharmacists who successfully complete the program. Accreditation number: 240187

Learning Objectives

Upon completion of this continuing education program participants will be better able to:

  • Describe the burden of IBS on patients and the healthcare system
  • Identify which tests are critical for IBS diagnosis and monitoring, and which tests are less useful
  • Identify pharmacological and nonpharmacological treatments for IBS and its subtypes
  • Recognize red flag signs and symptoms that indicate a diagnosis other than IBS

CCCEP
Accredited
Course

OPQ
Accredited
Course

Take this Course